So there was overlap for the criteria for AHD identification and eligibility for the LF-LAM test using the different criteria, with some of the patients also being seriously ill, and having CD4 count of less than 200 cells/mm3, and WHO stage 3 and 4. This evidence concerns the gene CD4 and mitochondrial DNA depletion syndrome 4a.